Antidepressant-like effect of endomorphin-1 and endomorphin-2 in mice.

Neuropsychopharmacology 2007 Apr 5;32(4):813-21. Epub 2006 Jul 5.

Laboratory of Biomolecular Chemistry, Medical University of Lodz, Lodz, Poland.

Endomorphin-1 (Tyr-Pro-Trp-Phe-NH(2)) and endomorphin-2 (Tyr-Pro-Phe-Phe-NH(2)) are two recently isolated mu-opioid selective peptides with a potent antinociceptive activity, involved in a number of physiological processes, including food intake, vasomotricity, sexual behavior, as well as neuroendocrine and cardiorespiratory functions. The neuroanatomical distribution of endomorphins prompted us to study their antidepressant activity in two animal behavioral models of depression: forced-swimming and tail-suspension tests. In both tests, the intracerebroventricular (i.c.v.) injection of either endomorphin-1 or endomorphin-2 significantly decreased the duration of immobility, interpreted as an expression of 'behavioral despair', which could be related to the depression syndrome. These effects of endomorphins did not result from the stimulation of the animal motor activity. We have also demonstrated that the antidepressant-like effect of endomorphins was antagonized by the universal opioid antagonist, naloxone and the mu-opioid receptor selective antagonist, beta-funaltrexamine. In contrast, this effect was not antagonized by delta- and kappa-opioid receptor selective antagonists, naltrindole and nor-binaltorphimine, respectively. The results of the present study demonstrate that endomorphin-1 and endomorphin-2 produce potent antidepressant-like effects after i.c.v. injection in mice. We may suggest that endomorphins and the mu-opioid receptors might be involved in the physiopathology of depressive disorders, and that the endomorphinergic system could serve as a novel target for the development of antidepressant drugs.

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.npp.1301149DOI Listing
April 2007
8 Reads

Publication Analysis

Top Keywords

endomorphin-1 endomorphin-2
12
icv injection
8
receptor selective
8
duration immobility
4
decreased duration
4
endomorphin-2 decreased
4
injection endomorphin-1
4
injection mice
4
antidepressant-like effects
4
effects icv
4
immobility interpreted
4
endomorphin-2 produce
4
'behavioral despair'
4
expression 'behavioral
4
produce potent
4
interpreted expression
4
potent antidepressant-like
4
tests intracerebroventricular
4
delta- kappa-opioid
4
behavioral models
4

References

(Supplied by CrossRef)

M Al-Khrasani et al.
Reg Pept 2003

A Asakawa et al.
Neuroreport 1998

M Babbini et al.
Br J Pharmacol 1972

JD Belluzi et al.
Nature 1977

A Besson et al.
Psychopharmacol (Berlin) 1996

JA Bodkin et al.
J Clin Psychopharmacol 1995

M Bourin et al.
Fundam Clin Pharmacol 1990

E Bujdoso et al.
Neuroscience 2003

E Bujdoso et al.
Peptides 2001

HC Champion et al.
Peptides 1997

C Chavkin et al.
Science 1982

Similar Publications